Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.7%

98 terminated/withdrawn out of 1276 trials

Success Rate

88.4%

+1.8% vs industry average

Late-Stage Pipeline

11%

135 trials in Phase 3/4

Results Transparency

1%

10 of 746 completed trials have results

Key Signals

143 recruiting10 with results73 terminated25 withdrawn

Enrollment Performance

Analytics

N/A
530(65.0%)
Phase 4
97(11.9%)
Phase 2
94(11.5%)
Phase 1
44(5.4%)
Phase 3
38(4.7%)
Early Phase 1
12(1.5%)
815Total
N/A(530)
Phase 4(97)
Phase 2(94)
Phase 1(44)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1276)

Showing 20 of 1276 trials
NCT07251881Not ApplicableRecruiting

SuperCable vs. Conventional Steel Wire for Closure After a Median Sternotomy

Role: lead

NCT07727356Not ApplicableActive Not Recruiting

EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders

Role: collaborator

NCT07725432Phase 2Active Not Recruiting

Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation

Role: lead

NCT07006311Not ApplicableTerminated

Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol

Role: lead

NCT06685965Phase 2Completed

A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances

Role: collaborator

NCT07713654Not ApplicableCompleted

Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study

Role: lead

NCT05890469Not ApplicableCompleted

Effect of Implant Surface Material and Topography on Bone Regeneration.

Role: collaborator

NCT07689253Completed

Does Anesthesia Technique Impact on the Long-term Outcome 5 and 10 Years After the First Intervention in Primary Breast Cancer Surgery? A Follow-up Analysis.

Role: lead

NCT07687264Not ApplicableNot Yet Recruiting

Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Role: lead

NCT07687147Not ApplicableRecruiting

Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions

Role: lead

NCT05163600Not ApplicableRecruiting

The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)

Role: lead

NCT06480656Not ApplicableCompleted

Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease

Role: lead

NCT07042256Not ApplicableRecruiting

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

Role: lead

NCT06834152Recruiting

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

Role: lead

NCT06620380Phase 2Recruiting

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

Role: lead

NCT07284628Phase 2Recruiting

Vortioxetine for Newly Diagnosed Glioblastoma

Role: lead

NCT07664540Not ApplicableNot Yet Recruiting

Fasting, Exercise, and Diet to Activate Autophagy in Depression

Role: lead

NCT07659769Recruiting

Global Healthcare Study on Hidradenitis Suppurativa

Role: collaborator

NCT07659756Recruiting

Global Healthcare Study on Atopic Dermatitis

Role: collaborator

NCT07524023Not ApplicableActive Not Recruiting

Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

Role: lead